Paasa Logo
First Tracks Biotherapeutics Inc logo
TRAXNASDAQMarket closedOpens 9:30am ET

First Tracks Biotherapeutics Inc

$36.65Last updated
+$2.23 (6.46%)Past day
Timezone

First Tracks Biotherapeutics Inc (NASDAQ: TRAX) is trading at $36.65, about ₹3,520 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, up 6.46% today. Indian residents can buy First Tracks Biotherapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$34.40
Previous close:$34.42
Volume:674.50K

Today's low

$33.55

Today's high

$37.24

52 week low

$14.72

52 week high

$49.91

TRAX opened at $34.40, closed previously at $34.42, and has traded between $14.72 and $49.91 over the past 52 weeks.

About

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

Country
US
CEO
Daniel R. Faga
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
104
Sector
Healthcare
IPO date
20/04/2026

Key statistics

Avg. volume

727.20K

Market cap

$1.28B

P/E Ratio

-9.77

Price-to-sales ratio

0.00

Enterprise value

$1.11B

Free cash flow yield

-8.57%

Debt-to-equity ratio

0.03

Return on equity

-47.43%

ROIC

-80.30%

Beta

3.37

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

$0.00

Free cash flow

-$143.01M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

-$178.45M

Revenue growth

—

How to buy First Tracks Biotherapeutics from India

Indian residents can buy First Tracks Biotherapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for First Tracks Biotherapeutics and place an order

    Find First Tracks Biotherapeutics by name or by its ticker, TRAX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. First Tracks Biotherapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your First Tracks Biotherapeutics position in USD and INR. First Tracks Biotherapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in First Tracks Biotherapeutics from India

Trading and taxes when buying First Tracks Biotherapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneFirst Tracks Biotherapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy First Tracks Biotherapeutics stock?

Yes. First Tracks Biotherapeutics (TRAX) has been listed on NASDAQ since 2026, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one First Tracks Biotherapeutics share cost in rupees?

One First Tracks Biotherapeutics share is $36.65 — about ₹3,520 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the First Tracks Biotherapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying First Tracks Biotherapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of First Tracks Biotherapeutics?

Yes. One First Tracks Biotherapeutics share is $36.65, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in First Tracks Biotherapeutics.

How are gains on First Tracks Biotherapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the First Tracks Biotherapeutics price. Paasa issues a capital-gains statement for your return.

Does First Tracks Biotherapeutics pay a dividend?

No. First Tracks Biotherapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade First Tracks Biotherapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on First Tracks Biotherapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare First Tracks Biotherapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your First Tracks Biotherapeutics holding, its cost and its closing value.

How do I sell First Tracks Biotherapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.